Preliminary Experience of Extracorporeal Cytokine Hemoadsorption during Left Ventricular Assist Device Implantation in Cardiogenic Shock Patients.

Jonas PauschJulian MersmannOliver D BhadraMarkus J BartenYousuf Al AlassarLeonie Schulte-UentropHermann ReichenspurnerAlexander M Bernhardt

Published in: The Thoracic and cardiovascular surgeon (2022)

Extracorporeal cytokine hemoadsorption during high-risk LVAD implantation was not associated with a decrease of postoperative vasopressor support, improved hemodynamics, or an accelerated lactate clearance.

Keyphrases

left ventricular assist device
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
patient reported